ThinkEquity initiated coverage of Atlas Critical Minerals with a Buy rating and $15 price target. The firm says Atlas is a funded Brazil critical-minerals option, not an earnings story. The analyst sees "asymmetry" between the stock's current enterprise value and the company's "three probability-adjusted technical paths" of Alto Paranaiba rare earths, Malacacheta graphite, and Rio Piracicaba iron ore cash offset.